author-photo

Christopher F. Nicodemus

Wellesley College

48

Papers

820

Citations

Citation Trend

Filter By

Papers (35) Sort By

Journal Conference Others

IgE-based therapeutic combination enhances anti-tumor response in preclinical models of pancreatic cancer.

2021 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Final survival follow-up and translational associations using interval indirect immunization with oregovomab (O) and poly ICLC in patients (pts) with recurrent platinum-resistant ovarian cancer (PROC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PR15: A novel NK cell-targeted therapeutic strategy against pancreatic cancer

2020 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study

2020 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Correction to: Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients (Cancer Immunology, Immunotherapy, (2020), 69, 3, (383-397), 10.1007/s00262-019-02456-z)

2020 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (2)
302 A phase IB study of indirect immunization with Oregovomab and TLR3 stimulation with hiltonol® (H) in patients with recurrent platinum resistant ovarian cancer (PROC)

2019
Show All
- Source
- Cite
- Save
Citations (1)
Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma

2019 American Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (8)
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors

2018 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (11)
Abstract A30: AR20.5-based novel immunotherapy for pancreatic cancer

2017 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Prospective evaluation of front-line chemo-immunotherapy (C-IT) with oregovomab (2 alternative dosing schedules) carboplatin-paclitaxel (C-P) in advanced ovarian cancer (OC)

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)